<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04217655</url>
  </required_header>
  <id_info>
    <org_study_id>20200102-001</org_study_id>
    <nct_id>NCT04217655</nct_id>
  </id_info>
  <brief_title>Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules</brief_title>
  <official_title>Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuzhou Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xuzhou Central Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators aim to compare the diagnostic accuracy and radiation exposure between low-dose
      and standard-dose computed tomography-guided core needle biopsy for lung nodules.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At present, low-dose scanning protocol is widely used in computed tomography-guided
      interventions because these procedures usually require repeat scans, which causes more
      radiation exposure to the patients. Computed tomography-guided core needle biopsy is widely
      used in diagnosis of lung nodules with an overall diagnostic accuracy of 93%-97%. Compared
      with the large lung lesions, computed tomography-guided core needle biopsy for lung nodules
      might require more scanning to adjust the position of needle tip. Therefore, it might expose
      the patients to more radiation. However, studies regarding computed tomography-guided core
      needle biopsy for lung nodules are still lacking.

      In this study, investigators aim to compare the diagnostic accuracy and radiation exposure
      between low-dose and standard-dose computed tomography-guided core needle biopsy for lung
      nodules.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy</measure>
    <time_frame>From the date of randomization until the date of first documented final diagnosis, assessed up to 12 months</time_frame>
    <description>Diagnostic accuracy is defined as the biopsy diagnosis matches with the final diagnosis. The final diagnosis is made according to the surgical or follow-up findings.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiation dose</measure>
    <time_frame>From the date of randomization until the date of first documented biopsy procedures, assessed up to 1 day.</time_frame>
    <description>Radiation dose is the radiation exposure from the computed tomography device to patients.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Lung; Node</condition>
  <arm_group>
    <arm_group_label>Low-dose computed tomography group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo low-dose computed tomography-guided lung biopsy for lung nodule on day 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard-dose computed tomography group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergo standard-dose computed tomography-guided lung biopsy for lung nodule on day 1.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Low-dose computed tomography</intervention_name>
    <description>Radiation dose under the low-dose protocol computed tomography (120 kilovolt, 15 milliampere seconds)</description>
    <arm_group_label>Low-dose computed tomography group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Standard-dose computed tomography</intervention_name>
    <description>Radiation dose under the standard-dose protocol computed tomography (120 kilovolt, 150 milliampere seconds)</description>
    <arm_group_label>Standard-dose computed tomography group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Non-diagnostic lung lesions (no definitive pathological diagnosis);

          2. Lesion size between 5 and 30 mm;

          3. Solid lung lesions.

        Exclusion Criteria:

          1. The lesion which has been punctured previously;

          2. A lesion that had shrunk in size or a lesion with a stable size for 1 year;

          3. Severe dysfunction in heart, lung and coagulation function;

          4. Patients who refused to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xian-Chi Li, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuzhou Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xuzhou Central Hospital</name>
      <address>
        <city>Xuzhou</city>
        <state>Jiangsu</state>
        <zip>221009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Fu YF, Li GC, Xu QS, Shi YB, Wang C, Wang T. Computed tomography-guided lung biopsy: a randomized controlled trial of low-dose versus standard-dose protocol. Eur Radiol. 2020 Mar;30(3):1584-1592. doi: 10.1007/s00330-019-06464-6. Epub 2019 Nov 27.</citation>
    <PMID>31776740</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 1, 2020</study_first_submitted>
  <study_first_submitted_qc>January 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2020</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is not a plan to make individual participant data available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

